51P Translational analyses of the DeCidE phase II clinical study in advanced ovarian cancer patients reveal a substantial role for B-cells in the clinical benefit derived from maveropepimut-S (MVP-S) treatment
Dorigo, O., Dirk, B., Bydoun, M., Ebrahimizadeh, W., Omar, T., Kennedy, B., Torrey, H.T., Kaliaperumal, V., Kelly, E., Bramhecha, Y., Hrytsenko, O., Fiset, S., Hirsch, H., Graff, J.
Published in Annals of oncology (01.12.2021)
Published in Annals of oncology (01.12.2021)
Get full text
Journal Article